Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nature's Sunshine Products Return on Tangible Equity 2010-2023 | NATR

Current and historical return on tangible equity values for Nature's Sunshine Products (NATR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Nature's Sunshine Products Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $0.02B $0.16B 9.87%
2023-09-30 $0.01B $0.15B 5.38%
2023-06-30 $0.01B $0.15B 3.42%
2023-03-31 $0.00B $0.15B 2.76%
2022-12-31 $0.00B $0.15B 0.00%
2022-09-30 $0.01B $0.14B 7.37%
2022-06-30 $0.02B $0.14B 10.61%
2022-03-31 $0.02B $0.15B 14.52%
2021-12-31 $0.03B $0.16B 19.43%
2021-09-30 $0.02B $0.15B 14.84%
2021-06-30 $0.02B $0.15B 16.19%
2021-03-31 $0.02B $0.14B 15.73%
2020-12-31 $0.02B $0.16B 15.28%
2020-09-30 $0.02B $0.15B 12.41%
2020-06-30 $0.01B $0.14B 8.37%
2020-03-31 $0.01B $0.13B 6.26%
2019-12-31 $0.01B $0.13B 5.60%
2019-09-30 $0.00B $0.13B 2.44%
2019-06-30 $0.00B $0.12B 2.46%
2019-03-31 $0.00B $0.12B 0.00%
2018-12-31 $-0.00B $0.12B -1.65%
2018-09-30 $-0.02B $0.12B -13.25%
2018-06-30 $-0.02B $0.12B -12.12%
2018-03-31 $-0.02B $0.12B -11.83%
2017-12-31 $-0.01B $0.12B -10.00%
2017-09-30 $-0.00B $0.14B -2.26%
2017-06-30 $-0.00B $0.13B -0.74%
2017-03-31 $0.00B $0.13B 1.47%
2016-12-31 $0.00B $0.13B 1.46%
2016-09-30 $0.01B $0.14B 9.42%
2016-06-30 $0.01B $0.14B 8.82%
2016-03-31 $0.01B $0.14B 8.89%
2015-12-31 $0.02B $0.14B 11.94%
2015-09-30 $0.01B $0.13B 6.06%
2015-06-30 $0.01B $0.13B 4.53%
2015-03-31 $0.01B $0.13B 4.68%
2014-12-31 $0.01B $0.13B 8.08%
2014-09-30 $0.02B $0.14B 13.59%
2014-06-30 $0.02B $0.12B 18.22%
2014-03-31 $0.02B $0.11B 20.72%
2013-12-31 $0.02B $0.10B 16.07%
2013-09-30 $0.02B $0.10B 17.43%
2013-06-30 $0.02B $0.12B 18.03%
2013-03-31 $0.02B $0.12B 19.78%
2012-12-31 $0.02B $0.12B 22.75%
2012-09-30 $0.03B $0.11B 28.50%
2012-06-30 $0.02B $0.10B 22.16%
2012-03-31 $0.02B $0.10B 22.22%
2011-12-31 $0.02B $0.09B 23.68%
2011-09-30 $0.01B $0.08B 13.25%
2011-06-30 $0.01B $0.08B 8.33%
2011-03-31 $0.00B $0.07B 1.49%
2010-12-31 $-0.00B $0.07B -3.13%
2010-09-30 $0.00B $0.07B 4.90%
2010-06-30 $0.01B $0.06B 19.05%
2010-03-31 $0.01B $0.06B 22.12%
2009-12-31 $0.01B $0.06B 13.79%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.363B $0.445B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.003B 27.54
Chugai Pharmaceutical (CHGCY) Japan $52.278B 22.70
Takeda Pharmaceutical (TAK) Japan $41.902B 6.79
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.192B 24.36
Shionogi (SGIOY) Japan $14.152B 12.24
Sandoz Group AG (SDZNY) Switzerland $13.930B 0.00
Neurocrine Biosciences (NBIX) United States $13.135B 54.54
United Therapeutics (UTHR) United States $11.197B 11.99
Catalent (CTLT) United States $10.040B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.926B 7.02
Ionis Pharmaceuticals (IONS) United States $5.929B 0.00
Revolution Medicines (RVMD) United States $5.751B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.991B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 0.00
Indivior (INDV) United States $2.554B 11.87
Evotec AG (EVO) Germany $2.505B 0.00
Summit Therapeutics (SMMT) United States $2.456B 0.00
Corcept Therapeutics (CORT) United States $2.389B 24.16
Dyne Therapeutics (DYN) United States $2.056B 0.00
PTC Therapeutics (PTCT) United States $1.940B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.786B 18.45
NewAmsterdam Pharma (NAMS) Netherlands $1.779B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.725B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.664B 9.85
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.570B 0.00
Ardelyx (ARDX) United States $1.508B 0.00
4D Molecular Therapeutics (FDMT) United States $1.292B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.240B 11.65
Pacira BioSciences (PCRX) United States $1.221B 12.15
Soleno Therapeutics (SLNO) United States $1.217B 0.00
Collegium Pharmaceutical (COLL) United States $1.139B 7.01
Xencor (XNCR) United States $1.123B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.060B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.913B 0.00
Cronos Group (CRON) Canada $0.905B 0.00
Cassava Sciences (SAVA) United States $0.849B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.37
ARS Pharmaceuticals (SPRY) United States $0.817B 0.00
Enliven Therapeutics (ELVN) United States $0.809B 0.00
Sage Therapeutics (SAGE) United States $0.801B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
Ocular Therapeutix (OCUL) United States $0.776B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.722B 0.00
Silence Therapeutics (SLN) United Kingdom $0.678B 0.00
Savara (SVRA) United States $0.664B 0.00
Siga Technologies (SIGA) United States $0.593B 8.78
Lyell Immunopharma (LYEL) United States $0.567B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.557B 0.00
Verve Therapeutics (VERV) United States $0.555B 0.00
OmniAb (OABI) United States $0.547B 0.00
Korro Bio (KRRO) United States $0.535B 0.00
Exscientia (EXAI) United Kingdom $0.513B 0.00
Altimmune (ALT) United States $0.490B 0.00
KalVista Pharmaceuticals (KALV) United States $0.488B 0.00
ProKidney (PROK) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.454B 0.00
Larimar Therapeutics (LRMR) United States $0.417B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.397B 0.00
Heron Therapeutics (HRTX) United States $0.397B 0.00
Tourmaline Bio (TRML) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.383B 72.50
Harrow (HROW) United States $0.370B 0.00
Esperion Therapeutics (ESPR) United States $0.369B 0.00
Bioventus (BVS) United States $0.355B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.282B 0.00
ESSA Pharma (EPIX) Canada $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.272B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Nanobiotix S.A (NBTX) France $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.242B 0.00
Telomir Pharmaceuticals (TELO) United States $0.236B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Avita Medical (RCEL) United States $0.222B 0.00
Acrivon Therapeutics (ACRV) United States $0.213B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Prelude Therapeutics (PRLD) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.154B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 13.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.134B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.67
GlycoMimetics (GLYC) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.121B 0.00
Citius Pharmaceuticals (CTXR) United States $0.120B 0.00
FibroGen (FGEN) United States $0.114B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
OptiNose (OPTN) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.095B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.073B 5.95
Journey Medical (DERM) United States $0.069B 0.00
Tempest Therapeutics (TPST) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
Nutriband (NTRB) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
CERo Therapeutics Holdings (CERO) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
TherapeuticsMD (TXMD) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.11